GEA will equip Angola’s new Bio-Veterinary Center with centrifugation and aseptic valve technology to support local vaccine production, reduce import dependency and meet biopharmaceutical manufacturing standards.

A new high-volume tablet press delivers up to 1.14 million tablets hourly, supports complex bilayer formulations, and enables faster, efficient production.

The GEA kytero 2000 is now fully compatible with Rockwell's latest hardware and software solutions, offering customers an integrated, digitized centrifuge solution.

GEA and I&L Biosystems partnered to distribute the GEA kytero 10 in Benelux, the world's smallest disposable separator for enhancing small-batch biopharmaceutical processing efficiency.

Commissioned Q1 2025, PSD-3 enables nanogram/m³ OEL handling at Chugai’s FJ3 Fujieda site, advancing high-containment automation and pharmaceutical safety standards.

With throughputs of 15–300 L/h and 20,000× g-force, GEA’s separator gently processes cell cultures, removing fine particles while minimizing shear stress.

It is ideal for small-scale biopharmaceutical, food, and new food industries, particularly for product development and cell separation.

GEA has expanded its tank cleaning portfolio with two serviceable models, making industrial cleaning more efficient, cost-effective, and sustainable.

Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It combines GEA’s engineering expertise with Hovione’s development and manufacturing experience and both parties commit to partner to accelerate the adoption of Continuous Tableting technology.